Publications by authors named "Priscilla de Albuquerque Ribeiro Gondinho"
FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study.
Priscilla de Albuquerque Ribeiro Gondinho Paulo Goberlânio de Barros Silva Mário Roberto Pontes Lisboa Bruno Almeida Costa Duílio Reis da Rocha Filho
Int J Clin Oncol
December 2020
Background: Colorectal carcinoma (CRC) is widely treated by chemotherapy based on an intensely neurotoxic drug: oxaliplatin (OXL). We objective to evaluate prospectively the orofacial neurotoxicity during FLOX (fluorouracil + leucovorin + OXL) chemotherapy.
Methods: So, 46 patients with CRC were prospectively evaluated during FLOX chemotherapy by 3 cycles (C) of 6 weeks (W) each.